BMY logo

Bristol-Myers Squibb Company (BMY)

Profile

Full Name

Bristol-Myers Squibb Company

Ticker

NYSE: BMY

Exchange

NYSE

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

United States

IPO

June 1, 1972

Indexes

S&P 500

Website

http://www.bms.com

Employees

34100

Key Details

Price

$46.86(-3.42%)

Market cap

Last Dividend

$0.62

TTM Dividend yield

5.25%

Annual revenue

$48.30B(+7.32% YoY)

Annual EPS

-$4.41(-214.25% YoY)

PE ratio

17.55

Next earnings date

Jul 31, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $46.86
    BMY price is $46.86

    30-Day Relative Volume

    0.99
    BMY 30-day relative volume is 0.99

    Price Performance

    Price Most recent change

    -3.42%
    BMY price was down -3.42% on Jul 11, 2025

    Price YTD change

    -17.15%
    BMY price is down -17.15% since January 1st

    Price 1-year change

    +14.99%
    BMY price is up +14.99% year-on-year

    Price 3-year change

    -37.98%
    BMY price is down -37.98% over the past 3 years

    Price Range

    Price All-time high

    $81.44
    BMY price is currently -42.46% below its historical high of $81.44

    Price 3-year low

    $39.35
    BMY price is currently +19.09% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $95.36B
    BMY market capitalization is $95.36 billion

    Market cap 3-year change

    -40.89%
    BMY market capitalization is down -40.89% over the past 3 years

    Market cap All-time high

    $172.50B
    BMY market capitalization is currently -44.72% below its historical high of $172.50 billion

    Market cap sector rank

    98.35%
    BMY market capitalization is higher than 98.35% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.4%
    BMY shares outstanding is up +0.4% year-on-year

    Shares Outstanding 3-Year Change

    -4.68%
    BMY shares outstanding is down -4.68% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.25
    BMY beta is 0.25

    200-day SMA

    $54.00
    BMY price is currently -13.21% below its 200-day simple moving average

    50-day SMA

    $47.70
    BMY price is currently -1.77% below its 50-day simple moving average

    RSI

    45.50
    BMY 14-day relative strength index is 45.50

    Volume

    0.99
    BMY 30-day relative volume is 0.99

    ATR

    $1.03
    BMY average true range is $1.03

    10-day Historical Volatility

    28.28%
    BMY 10-day historical volatility is 28.28%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.62
    BMY last dividend was $0.62 per share, with an ex-dividend date of July 3, 2025

    Next Dividend

    -
    BMY next dividend has not yet been announced

    Dividend per share

    Dividend per share

    $2.40
    BMY annual dividend per share is $2.40

    Dividend per share Sector Rank

    74.12%
    BMY annual dividend per share is higher than 74.12% of companies in Healthcare sector

    Dividend per share 1-Year Change

    +5.26%
    BMY annual dividend per share is up +5.26% year-on-year

    Dividend per share 3-Year Change

    +22.45%
    BMY annual dividend per share is up +22.45% over the past 3 years

    Dividend yield

    Dividend yield

    5.12%
    BMY annual dividend yield is 5.12%

    Dividend yield Sector Rank

    85.71%
    BMY annual dividend yield is higher than 85.71% of companies in Healthcare sector

    Other

    Payout ratio

    -54.35%
    BMY annual payout ratio is -54.35%

    Dividends paid

    $4.86B
    BMY annual dividends paid is $4.86 billion

    Free cash flow

    $13.94B
    BMY annual free cash flow is $13.94 billion

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $48.30B
    BMY annual revenue is $48.30 billion

    Revenue Analysts estimate

    $46.16B
    BMY annual revenue is currently +4.63% higher than the consensus analysts' forecast

    Revenue 1-year change

    +7.32%
    BMY annual revenue is up +7.32% year-on-year

    Revenue Sector rank

    98.05%
    BMY annual revenue is higher than 98.05% of companies in Healthcare sector

    EPS

    EPS

    -$4.41
    BMY annual earnings per share is -$4.41

    EPS Analysts estimate

    $6.76
    BMY annual earnings per share is currently -165.19% lower than the consensus analysts' forecast

    EPS 1-year change

    -214.25%
    BMY annual earnings per share is down -214.25% year-on-year

    EPS Sector rank

    21.88%
    BMY annual earnings per share is higher than 21.88% of companies in Healthcare sector

    Profit

    Gross profit

    $34.33B
    BMY annual gross profit is $34.33 billion

    Gross margin

    71.08%
    BMY annual gross profit margin is 71.08%

    Operating profit

    $5.89B
    BMY annual operating income is $5.89 billion

    Operating margin

    12.19%
    BMY annual operating profit margin is 12.19%

    Net income

    -$8.95B
    BMY annual net profit is -$8.95 billion

    Net margin

    -18.53%
    BMY annual net profit margin is -18.53%

    Expenses

    Total expenses

    $42.41B
    BMY annual total expenses is $42.41 billion

    Operating expenses

    $28.45B
    BMY annual total operating expenses is $28.45 billion

    Cost of goods sold

    $13.97B
    BMY annual cost of goods sold is $13.97 billion

    Selling, general & administrative expenses

    $8.41B
    BMY annual SGA is $8.41 billion

    Depreciation and amortization

    $9.60B
    BMY annual depreciation & amortization is $9.60 billion

    Interest expense

    $1.95B
    BMY annual interest expense is $1.95 billion

    Income tax

    $554.00M
    BMY annual income tax is $554.00 million

    EBIT & EBITDA

    EBIT

    -$6.43B
    BMY annual earnings before interest & taxes is -$6.43 billion

    EBITDA

    $2.44B
    BMY annual EBITDA is $2.44 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $92.60B
    BMY annual total assets is $92.60 billion

    Non current assets

    $62.82B
    BMY annual long term assets is $62.82 billion

    Current assets

    $10.35B
    BMY annual total current assets is $10.35 billion

    Cash and cash equivalents

    $10.35B
    BMY annual cash & cash equivalents is $10.35 billion

    Accounts receivable

    $9.01B
    BMY annual accounts receivable is $9.01 billion

    Inventory

    $2.56B
    BMY annual inventory is $2.56 billion

    Liabilities

    Total liabilities

    $76.22B
    BMY annual total liabilities is $76.22 billion

    Long term liabilities

    $52.44B
    BMY annual total long term liabilities is $52.44 billion

    Current liabilities

    $23.77B
    BMY annual total current liabilities is $23.77 billion

    Accounts payable

    $3.60B
    BMY annual accounts payable is $3.60 billion

    Debt

    Total debt

    $51.20B
    BMY annual total debt is $51.20 billion

    Total debt 1-year change

    +23.48%
    BMY annual total debt is up +23.48% year-on-year

    Long term debt

    $48.97B
    BMY annual long term debt is $48.97 billion

    Short term debt

    $2.23B
    BMY annual short term debt is $2.23 billion

    Equity & Capital

    Shareholders equity

    $16.34B
    BMY annual stockholders equity is $16.34 billion

    Book value

    $16.34B
    BMY annual book value is $16.34 billion

    Retained earnings

    $14.91B
    BMY annual retained earnings is $14.91 billion

    Working capital

    $6.01B
    BMY annual working capital is $6.01 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $15.19B
    BMY annual cash flow from operations is $15.19 billion

    Cash from operations 1-year change

    +9.6%
    BMY annual cash flow from operations is up +9.6% year-on-year

    Cash from investing

    -$21.35B
    BMY annual cash flow from investing activities is -$21.35 billion

    Cash from investing 1-year change

    -830.37%
    BMY annual cash flow from investing activities is down -830.37% year-on-year

    Cash from financing

    $5.13B
    BMY annual cash flow from financing activities is $5.13 billion

    Cash from financing 1-year change

    +154.45%
    BMY annual cash flow from financing activities is up +154.45% year-on-year

    CAPEX

    CAPEX

    $1.25B
    BMY annual capital expenditures is $1.25 billion

    CAPEX 1-year change

    +3.23%
    BMY annual capital expenditures is up +3.23% year-on-year

    Free Cash Flow

    Free cash flow

    $13.94B
    BMY annual free cash flow is $13.94 billion

    Free cash flow 1-year change

    +10.2%
    BMY annual free cash flow is up +10.2% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    71.08%
    BMY annual gross profit margin is 71.08%

    Operating margin

    12.19%
    BMY annual operating profit margin is 12.19%

    Net margin

    -18.53%
    BMY annual net profit margin is -18.53%

    ROA & ROE

    ROA

    -9.53%
    BMY annual return on assets is -9.53%

    ROE

    -39.01%
    BMY annual return on equity is -39.01%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    17.55
    BMY price to earnings ratio is 17.55

    PE ratio Sector rank

    37.56%
    BMY price to earnings ratio is higher than 37.56% of companies in Healthcare sector

    PB Ratio

    PB ratio

    5.48
    BMY price to book ratio is 5.48

    PB ratio Sector rank

    81.39%
    BMY price to book ratio is higher than 81.39% of companies in Healthcare sector

    PS Ratio

    PS ratio

    2.00
    BMY price to sales ratio is 2.00

    PS ratio Sector rank

    39.14%
    BMY price to sales ratio is higher than 39.14% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $135.73B
    BMY enterprise value is $135.73 billion

    Enterprise value Sector rank

    98.33%
    BMY enterprise value is higher than 98.33% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    8.38
    BMY EV/EBITDA is 8.38

    EV/EBITDA Sector rank

    80.56%
    BMY EV/EBITDA is higher than 80.56% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.25
    BMY annual current ratio is 1.25

    Quick ratio

    0.33
    BMY annual quick ratio is 0.33

    Leverage

    Debt to equity

    3.04
    BMY annual debt to equity ratio is 3.04

    Interest coverage ratio

    -3.30
    BMY annual interest coverage ratio is -3.30

    Risk & Stability

    Piotroski F-Score

    7
    BMY piotroski f-score is 7

    Altman Z-Score

    1.35
    BMY altman z-score is 1.35

    Analyst ratings

    Recent major analysts updates

    Apr 28, 25 Wells Fargo
    Equal-Weight
    Apr 23, 25 Jefferies
    Buy
    Apr 23, 25 Cantor Fitzgerald
    Neutral
    Apr 22, 25 Piper Sandler
    Overweight
    Apr 11, 25 UBS
    Neutral
    Apr 8, 25 Goldman Sachs
    Neutral
    Feb 7, 25 Wells Fargo
    Equal-Weight
    Feb 4, 25 Cantor Fitzgerald
    Neutral
    Jan 28, 25 Citigroup
    Neutral
    Jan 8, 25 Truist Securities
    Buy

    Institutional Ownership

    Screeners with BMY included

    Growing Shares Outstanding
    US stocks
    High Piotroski score stocks
    S&P 500 companies earnings calendar
    Stocks below SMA 200
    Stocks recommended to hold
    S&P 500 companies
    Stocks below analysts price target
    S&P 500 companies dividend calendar
    Healthcare sector
    • What is the ticker symbol for Bristol-Myers Squibb Company?
    • Does Bristol-Myers Squibb Company pay dividends?
    • What sector is Bristol-Myers Squibb Company in?
    • What industry is Bristol-Myers Squibb Company in?
    • What country is Bristol-Myers Squibb Company based in?
    • When did Bristol-Myers Squibb Company go public?
    • Is Bristol-Myers Squibb Company in the S&P 500?
    • Is Bristol-Myers Squibb Company in the NASDAQ 100?
    • Is Bristol-Myers Squibb Company in the Dow Jones?
    • When was Bristol-Myers Squibb Company's last earnings report?
    • When does Bristol-Myers Squibb Company report earnings?

    What is the ticker symbol for Bristol-Myers Squibb Company?

    The ticker symbol for Bristol-Myers Squibb Company is NYSE:BMY

    Does Bristol-Myers Squibb Company pay dividends?

    Yes, Bristol-Myers Squibb Company pays dividends. The last payment was $0.62, with an ex-dividend date on July 3, 2025

    What sector is Bristol-Myers Squibb Company in?

    Bristol-Myers Squibb Company is in the Healthcare sector

    What industry is Bristol-Myers Squibb Company in?

    Bristol-Myers Squibb Company is in the Drug Manufacturers - General industry

    What country is Bristol-Myers Squibb Company based in?

    Bristol-Myers Squibb Company is headquartered in United States

    When did Bristol-Myers Squibb Company go public?

    Bristol-Myers Squibb Company's initial public offering (IPO) was on June 1, 1972

    Is Bristol-Myers Squibb Company in the S&P 500?

    Yes, Bristol-Myers Squibb Company is included in the S&P 500 index

    Is Bristol-Myers Squibb Company in the NASDAQ 100?

    No, Bristol-Myers Squibb Company is not included in the NASDAQ 100 index

    Is Bristol-Myers Squibb Company in the Dow Jones?

    No, Bristol-Myers Squibb Company is not included in the Dow Jones index

    When was Bristol-Myers Squibb Company's last earnings report?

    Bristol-Myers Squibb Company's most recent earnings report was on April 24, 2025

    When does Bristol-Myers Squibb Company report earnings?

    The next expected earnings date for Bristol-Myers Squibb Company is July 31, 2025
    On this page